Abstract
Objective: Highlight, through a narrative review, the management and control measures of COVID-19 for pregnant women and the possible risks during vertical transmission and breastfeeding. PubMed and Science Direct databases were used, which portrayed articles on viral infections, COVID-19, pregnancy and breastfeeding. Bibliographic review: Physiological, metabolic and vascular disturbances can worsen the clinical presentation of COVID-19, promoting endothelial dysfunction, activation of the complement system, and a prothrombotic effect in pregnant women. There are no reports of the new coronavirus detection in amniotic and placental fluids, cord blood or breast milk. However, some studies suggest that vertical transmission of the virus is possible and a higher prevalence of premature births has been reported. Treatment begins when possible benefits outweigh the potential risks of therapy to the fetus. Final considerations: Procedures should be implemented to bridge knowledge gaps about the effect of COVID-19 on pregnancy, including health surveillance, epidemiological, socioeconomic, and seroprevalence surveys.